Non-Alcoholic Fatty Liver Disease and Vitamin D in the UK Biobank: A Two-Sample Bidirectional Mendelian Randomisation Study
The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Evidence for a role for vitamin D in non-alcoholic fatty liver disease (NAFLD) pathogenesis is conflicting. As Mendelian randomisation (MR) avoids many limitations of conventional observational studies, this two-sample bidirectional MR analysis was conducted to determine the following: (i) whether genetically predicted 25-hydroxyvitamin D [25(OH)D] levels are a risk factor for NAFLD, and (ii) whether genetic risk for NAFLD influences 25(OH)D levels. Single-nucleotide polymorphisms (SNPs) associated with serum 25(OH)D levels were obtained from the European ancestry-derived SUNLIGHT consortium. SNPs associated with NAFLD or NASH (p-value < 1 × 10−5) were extracted from previous studies and supplemented by genome-wide association studies (GWASs) performed in the UK Biobank. These GWASs were done both without (primary analysis) and with (sensitivity analysis) the population-level exclusion of other liver diseases (e.g., alcoholic liver diseases, toxic liver diseases, viral hepatitis, etc.). Subsequently, MR analyses were performed to obtain effect estimates using inverse variance weighted (IVW) random effect models. Cochran’s Q statistic, MR-Egger regression intercept, MR pleiotropy residual sum and outlier (MR-PRESSO) analyses were used to assess pleiotropy. No causal association of genetically predicted serum 25(OH)D (per standard deviation increase) with risk of NAFLD was identified in either the primary analysis: n = 2757 cases, n = 460,161 controls, odds ratio (95% confidence interval): 0.95 (0.76, −1.18), p = 0.614; or the sensitivity analysis. Reciprocally, no causal association was identified between the genetic risk of NAFLD and serum 25(OH)D levels, OR = 1.00 (0.99, 1.02, p = 0.665). In conclusion, this MR analysis found no evidence of an association between serum 25(OH)D levels and NAFLD in a large European cohort.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Interpreting findings from Mendelian randomization using the MR-Egger method.
Burgess, S., & Thompson, S. G. (2017) · European Journal of Epidemiology · doi:10.1007/s10654-017-0255-x · Cited by 4,571
Avoiding bias from weak instruments in Mendelian randomization studies
Burgess, S., Thompson, S. G., & CRP CHD Genetics Collaboration (2011) · International Journal of Epidemiology · doi:10.1093/ije/dyr036 · Cited by 3,952
Robust inference in summary data Mendelian randomization via the zero modal pleiotropy assumption
Hartwig, F. P., Davey Smith, G., & Bowden, J. (2017) · International Journal of Epidemiology · doi:10.1093/ije/dyx102 · Cited by 3,485
Mendelian Randomization as an Approach to Assess Causality Using Observational Data
Sekula, P., Del Greco M, F., Pattaro, C., & Köttgen, A. (2016) · Journal of the American Society of Nephrology · doi:10.1681/asn.2016010098 · Cited by 2,351 · cited 1×
“, genetic predictors of exposure) are randomised at conception in the absence of confounders [18].”
BackgroundVitamin D metabolism, mechanism of action, and clinical applications
Bikle, D. D. (2014) · Chemistry & Biology · doi:10.1016/j.chembiol.2013.12.016 · Cited by 1,933
A framework for the investigation of pleiotropy in two‐sample summary data Mendelian randomization
Bowden, J., Del Greco M, F., Minelli, C., Davey Smith, G., Sheehan, N., & Thompson, J. (2017) · Statistics in Medicine · doi:10.1002/sim.7221 · Cited by 1,887 · cited 1×
“The IVW-random effect estimates the causal relationship between exposure and outcome by performing a meta-analysis of the ratio of SNP-exposure effects on SNP-outcome effects weighted by the inverse variance of the SNP-exposure effects with heterogeneity adjustment [37,38].”
MethodEfficient Bayesian mixed-model analysis increases association power in large cohorts
Loh, P.-R., Tucker, G., Bulik-Sullivan, B. K., Vilhjálmsson, B. J., Finucane, H. K., Salem, R. M., Chasman, D. I., Ridker, P. M., Neale, B. M., Berger, B., et al. (2015) · Nature Genetics · doi:10.1038/ng.3190 · Cited by 1,507
Evaluating the potential role of pleiotropy in Mendelian randomization studies
Hemani, G., Bowden, J., & Davey Smith, G. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy163 · Cited by 1,496
Speliotes, E. K., Yerges-Armstrong, L. M., Wu, J., Hernaez, R., Kim, L. J., Palmer, C. D., Gudnason, V., Eiriksdottir, G., Garcia, M. E., Launer, L. J., et al. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1001324 · Cited by 984
Self-citationMixed model association for biobank-scale data sets
Loh, P.-R., Kichaev, G., Gazal, S., Schoech, A. P., & Price, A. L. (2017) · doi:10.1101/194944 · Cited by 788
Research works printed but not linked: 46
- Younossi, 2018, Global burden of NAFLD and NASH: Trends, predictions, risk factors and prevention, Nat. Rev. Gastroenterol. Hepatol., 15, 11, 10.1038/nrgastro.2017.109 · DOI · Paper page
- Bence, 2021, Metabolic drivers of non-alcoholic fatty liver disease, Mol. Metab., 50, 101143, 10.1016/j.molmet.2020.101143 · DOI · Paper page
- 2021, Dietary Treatment for NAFLD: New Clinical and Epidemiological Evidence and Updated Recommendations, Semin. Liver Dis., 41, 248, 10.1055/s-0041-1729971 · DOI
- Moore, 2019, From sugar to liver fat and public health: Systems biology driven studies in understanding non-alcoholic fatty liver disease pathogenesis, Proc. Nutr. Soc., 78, 290, 10.1017/S0029665119000570 · DOI · Paper page
- Gibson, 2018, Vitamin D status and associated genetic polymorphisms in a cohort of UK children with non-alcoholic fatty liver disease, Pediatr. Obes., 13, 433, 10.1111/ijpo.12293 · DOI
- Barchetta, I., Cimini, F.A., and Cavallo, M.G. (2020). Vitamin D and Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD): An Update. Nutrients, 12. · DOI · Paper page
- Pacifico, 2019, Association between Vitamin D Levels and Nonalcoholic Fatty Liver Disease: Potential Confounding Variables, Mini Rev. Med. Chem., 19, 310, 10.2174/1389557518666181025153712 · DOI
- Karatayli, 2020, Vitamin D in Preclinical Models of Fatty Liver Disease, Anticancer Res., 40, 527, 10.21873/anticanres.13981 · DOI
- Roth, 2012, Vitamin D deficiency in obese rats exacerbates nonalcoholic fatty liver disease and increases hepatic resistin and Toll-like receptor activation, Hepatology, 55, 1103, 10.1002/hep.24737 · DOI · Paper page
- Ma, 2020, Active vitamin D impedes the progression of non-alcoholic fatty liver disease by inhibiting cell senescence in a rat model, Clin. Res. Hepatol. Gastroenterol., 44, 513, 10.1016/j.clinre.2019.10.007 · DOI
- Rhee, 2013, High serum vitamin D levels reduce the risk for nonalcoholic fatty liver disease in healthy men independent of metabolic syndrome, Endocr. J., 60, 743, 10.1507/endocrj.EJ12-0387 · DOI
- Liu, 2020, Association of serum vitamin D level and nonalcoholic fatty liver disease: A meta-analysis, Eur. J. Gastroenterol. Hepatol., 32, 140, 10.1097/MEG.0000000000001486 · DOI
- Targher, 2007, Associations between serum 25-hydroxyvitamin D3 concentrations and liver histology in patients with non-alcoholic fatty liver disease, Nutr. Metab. Cardiovasc. Dis., 17, 517, 10.1016/j.numecd.2006.04.002 · DOI · Paper page
- Eraslan, 2013, Frequency of metabolic syndrome and 25-hydroxyvitamin D3 levels in patients with non-alcoholic fatty liver disease, Minerva Med., 104, 447
- Nelson, 2016, Vitamin D Deficiency Is Associated With Increased Risk of Non-alcoholic Steatohepatitis in Adults with Non-alcoholic Fatty Liver Disease: Possible Role for MAPK and NF-κB?, Am. J. Gastroenterol., 111, 852, 10.1038/ajg.2016.51 · DOI · Paper page
- Zhang, 2019, Vitamin D and nonalcoholic fatty liver disease, Curr. Opin. Clin. Nutr. Metab. Care, 22, 449, 10.1097/MCO.0000000000000605 · DOI
- Smith, 2003, ’Mendelian randomization‘: Can genetic epidemiology contribute to understanding environmental determinants of disease?, Int. J. Epidemiol., 32, 1, 10.1093/ije/dyg070 · DOI · Paper page
- Wang, 2018, Vitamin D and nonalcoholic fatty liver disease: Bi-directional mendelian randomization analysis, eBioMedicine, 28, 187, 10.1016/j.ebiom.2017.12.027 · DOI
- Yuan, 2022, Inverse association between serum 25-hydroxyvitamin D and nonalcoholic fatty liver disease, Clin. Gastroenterol. Hepatol., 21, 398, 10.1016/j.cgh.2022.01.021 · DOI
- Jiang, 2018, Genome-wide association study in 79,366 European-ancestry individuals informs the genetic architecture of 25-hydroxyvitamin D levels, Nat. Commun., 9, 260, 10.1038/s41467-017-02662-2 · DOI · Paper page
- Wolk, 2017, The seasonal importance of serum 25-hydroxyvitamin D for bone mineral density in older women, J. Intern. Med., 281, 167, 10.1111/joim.12563 · doi:10.1111/joim.12563
- Sudlow, C., Gallacher, J., Allen, N., Beral, V., Burton, P., Danesh, J., Downey, P., Elliott, P., Green, J., and Landray, M. (2015). UK biobank: An open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med., 12. · DOI · Paper page
- Bycroft, 2018, The UK Biobank resource with deep phenotyping and genomic data, Nature, 562, 203, 10.1038/s41586-018-0579-z · DOI · Paper page
- Eslam, 2020, Genetic contributions to NAFLD: Leveraging shared genetics to uncover systems biology, Nat. Rev. Gastroenterol. Hepatol., 17, 40, 10.1038/s41575-019-0212-0 · DOI · Paper page
- Hemani, 2018, The MR-Base platform supports systematic causal inference across the human phenome, eLife, 7, e34408, 10.7554/eLife.34408 · DOI · Paper page
- Pritchard, 2001, Linkage disequilibrium in humans: Models and data, Am. J. Hum. Genet., 69, 1, 10.1086/321275 · DOI · Paper page
- Li, 2021, Contribution of Rs780094 and Rs1260326 Polymorphisms in GCKR Gene to Non-alcoholic Fatty Liver Disease: A Meta-Analysis Involving 26,552 Participants, Endocr. Metab. Immune Disord. Drug Targets, 21, 1696, 10.2174/1871530320999201126202706 · doi:10.2174/1871530320999201126202706
- Pierce, 2011, Power and instrument strength requirements for Mendelian randomization studies using multiple genetic variants, Int. J. Epidemiol., 40, 740, 10.1093/ije/dyq151 · DOI · Paper page
- Burgess, 2013, Mendelian randomization analysis with multiple genetic variants using summarized data, Genet. Epidemiol., 37, 658, 10.1002/gepi.21758 · DOI · Paper page
- Bowden, 2015, Mendelian randomization with invalid instruments: Effect estimation and bias detection through Egger regression, Int. J. Epidemiol., 44, 512, 10.1093/ije/dyv080 · DOI · Paper page
- Bowden, 2016, Consistent Estimation in Mendelian Randomization with Some Invalid Instruments Using a Weighted Median Estimator, Genet. Epidemiol., 40, 304, 10.1002/gepi.21965 · DOI · Paper page
- Walker, 2019, Using the MR-Base platform to investigate risk factors and drug targets for thousands of phenotypes, Wellcome Open Res., 4, 113, 10.12688/wellcomeopenres.15334.1 · DOI
- Cohen, 2015, Cochran’s Q test was useful to assess heterogeneity in likelihood ratios in studies of diagnostic accuracy, J. Clin. Epidemiol., 68, 299, 10.1016/j.jclinepi.2014.09.005 · DOI · Paper page
- Verbanck, 2018, Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases, Nat. Genet., 50, 693, 10.1038/s41588-018-0099-7 · DOI · Paper page
- Rezaei, 2021, The Effects of Vitamin D Supplementation on Anthropometric and Biochemical Indices in Patients With Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis, Front. Pharmacol., 12, 732496, 10.3389/fphar.2021.732496 · DOI
- Bjelakovic, 2021, Vitamin D supplementation for chronic liver diseases in adults, Cochrane Database Syst. Rev., 8, CD011564
- Zhang, Z. (2022). Vitamin D and the Molecular Pathogenesis of Non-alcoholic Fatty Liver Disease. [Ph.D. Thesis, University of Leeds].
- Hayward, 2021, Detecting non-alcoholic fatty liver disease and risk factors in health databases: Accuracy and limitations of the ICD-10-AM, BMJ Open Gastroenterol., 8, e000572, 10.1136/bmjgast-2020-000572 · DOI
- Anstee, 2020, Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort, J. Hepatol., 73, 505, 10.1016/j.jhep.2020.04.003 · DOI · Paper page
- Ahn, 2010, Genome-wide association study of circulating vitamin D levels, Hum. Mol. Genet., 19, 2739, 10.1093/hmg/ddq155 · DOI · Paper page
- Wang, 2010, Common genetic determinants of vitamin D insufficiency: A genome-wide association study, Lancet, 376, 180, 10.1016/S0140-6736(10)60588-0 · DOI · Paper page
- Hartwig, 2021, Bias in two-sample Mendelian randomization when using heritable covariable-adjusted summary associations, Int. J. Epidemiol., 50, 1639, 10.1093/ije/dyaa266 · DOI · Paper page
- Luukkonen, 2015, Heterogeneity of non-alcoholic fatty liver disease, Liver Int., 35, 2498, 10.1111/liv.12970 · DOI
- Jiang, T., Gill, D., Butterworth, A.S., and Burgess, S. (2022). An empirical investigation into the impact of winner’s curse on estimates from Mendelian randomization. Int. J. Epidemiol. · doi:10.1101/2022.08.05.22278470
- Tilling, 2018, Collider scope: When selection bias can substantially influence observed associations, Int. J. Epidemiol., 47, 226, 10.1093/ije/dyx206 · DOI · Paper page
- Kim, M.S., Song, M., Shin, J.I., and Won, H.H. (2023). How to interpret studies using Mendelian randomisation. BMJ Evid.-Based Med., in press. · DOI
Metadata
- Authors
- Zhang, Z., Burrows, K., Fuller, H., Speliotes, E. K., Abeysekera, K. W. M., Thorne, J. L., Lewis, S. J., Zulyniak, M. A., & Moore, J. B.
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2023-03-16
- Volume
- 15
- Issue
- 6
- Pages
- 1442
- ISSN
- 2072-6643
- Cited by
- 13
- References
- 11
- Language
- en
- Funders
- Cancer Research UK (C18281/A29019, BRC-1215-20011, 217446/Z/19/Z)
- NIHR (C18281/A29019, BRC-1215-20011, 217446/Z/19/Z)
- Wellcome Trust (C18281/A29019, BRC-1215-20011, 217446/Z/19/Z)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Non-Alcoholic Fatty Liver Disease and Vitamin D in the UK Biobank: A Two-Sample Bidirectional Mendelian Randomisation Study. https://app.cochat.ai/papers/10.3390/nu15061442
- The paper
- Zhang, Z., Burrows, K., Fuller, H., Speliotes, E. K., Abeysekera, K. W. M., Thorne, J. L., Lewis, S. J., Zulyniak, M. A., & Moore, J. B. (2023). Non-Alcoholic Fatty Liver Disease and Vitamin D in the UK Biobank: A Two-Sample Bidirectional Mendelian Randomisation Study. Nutrients. https://doi.org/10.3390/nu15061442
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.